Is Intercostal Tube Enough in Management of Empyema

NCT ID: NCT06235359

Last Updated: 2024-01-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-31

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Is intercostal tube enough in management of empyema ?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Empyema refers to presence of pus in the pleural space -Causes Primary: bacterial Pneumonia (staph aureus, strept pneumonia , H.influenza) , TB

Secondry :

PostTraumati postoperative :open heart , esophageal, mediastinum , lung rupture of lung absess

-pathophysiology and stages During an inflammatory process such as pneumonia, there is an increase in fluid production in the pleural cavity known as the exudate stage. As the disease progresses microorganisms, usually bacteria, can colonize the fluid and generated an empyema. This fluid is characterized by elevated lactate dehydrogenase, proteins, neutrophils, and dead cells. Macroscopically is a thick opaque fluid found in the fibrinopurulent stage. After the resolution of the infection and as a consequence of the inflammation, there is a process of fibrosis that can lead to restriction of the lung parenchyma which is stage of chronic organization

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Empyema

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

intercostal tube

A chest tube is a hollow, flexible tube placed into the chest. It acts as a drain.

Chest tubes drain blood, fluid, or air from around your lungs, heart, or esophagus.

The tube around your lung is placed between your ribs and into the space between the inner lining and the outer lining of your chest cavity. This is called the pleural space. It allows your lungs to fully expand.

Group Type OTHER

intercostal tube

Intervention Type DEVICE

A chest tube is a hollow, flexible tube placed into the chest. It acts as a drain.

Chest tubes drain blood, fluid, or air from around your lungs, heart, or esophagus.

The tube around your lung is placed between your ribs and into the space between the inner lining and the outer lining of your chest cavity. This is called the pleural space. It allows your lungs to fully expand.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

intercostal tube

A chest tube is a hollow, flexible tube placed into the chest. It acts as a drain.

Chest tubes drain blood, fluid, or air from around your lungs, heart, or esophagus.

The tube around your lung is placed between your ribs and into the space between the inner lining and the outer lining of your chest cavity. This is called the pleural space. It allows your lungs to fully expand.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients admitted to Assuit university Hospital and diagnosed with empyema

Exclusion Criteria

* Patient diagnosed with Post-operative empyema
* Patient diagnosed with post traumatic empyema
* Patient diagnosed with Bronchopleural fistula
* Patient diagnosed with TB
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Islam Abdelfatah mahmoud

physician

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Islam abdelfatah, resident

Role: CONTACT

Phone: 01024984239

Email: [email protected]

Mahmoud khairy, professor

Role: CONTACT

Phone: 01098935293

Email: [email protected]

References

Explore related publications, articles, or registry entries linked to this study.

Ali I, Unruh H. Management of empyema thoracis. Ann Thorac Surg. 1990 Sep;50(3):355-9. doi: 10.1016/0003-4975(90)90474-k.

Reference Type BACKGROUND
PMID: 2400254 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

empyema

Identifier Type: -

Identifier Source: org_study_id